Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City
Patients with elevated Lp(a) levels were more likely to present with HFpEF and elevated LDL levels, although no significant associations were found with ASCVD risk factors, vascular, or valvular pathologies. The unexpectedly high Lp(a) levels in some individuals with similar risk profiles suggest the need for further research to refine guidelines for Lp(a) testing. Our study also highlighted the underutilization of Lp(a) testing in clinical practice, underscoring the importance of increasing awareness and improving ASCVD risk assessment strategies.
Authors
- Dimitrios Karamanis (ORCID: https://orcid.org/0000-0003-2003-7356)
- Vibhor Garg
- Paweł Borkowski (ORCID: https://orcid.org/0000-0001-8089-4101)
- Maisha Maliha (ORCID: https://orcid.org/0000-0001-8075-0052)
- Amrin Kharawala (ORCID: https://orcid.org/0000-0003-3989-4489)
- Vikyath Satish (ORCID: https://orcid.org/0000-0003-4954-2620)
- Tinatin Saralidze
- Leonidas Palaiodimos (ORCID: https://orcid.org/0000-0003-4682-5991)
- Sanjana Nagraj (ORCID: https://orcid.org/0000-0002-6230-7214)
- Natalia Nazarenko
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- University of Piraeus (GR)
- Jacobi Medical Center (US)
Publication Details
- Journal
- Heart Views
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/heartviews.heartviews_138_24
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00